Literature DB >> 2434206

Mammary and extramammary Paget's disease. An immunocytochemical and ultrastructural study.

N G Ordóñez, H Awalt, B Mackay.   

Abstract

Twenty-one cases of Paget's disease have been studied using histochemical, ultrastructural, and immunohistochemical methods. Eight of the tumors involved the nipple, and 13 were extramammary (11 vulvar and two anal). The antibodies used were directed against different classes of cytokeratin proteins, epithelial membrane antigen, carcinoembryonic antigen, gross cystic disease fluid protein-15, and S-100 protein. The findings of this study provide conclusive evidence that Paget's cells, regardless of their location, are adenocarcinoma cells. Intracytoplasmic mucin is scanty in Paget's cells within the nipple, but typically plentiful in the extramammary sites where the cells are frequently signet-ring cells. The common mechanism for the evolution of Paget's disease is extension of cells from an underlying carcinoma, but the possibility that some cases, particularly in the vulva, develop from intraepithelial precursors cannot be excluded.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2434206     DOI: 10.1002/1097-0142(19870315)59:6<1173::aid-cncr2820590624>3.0.co;2-r

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  10 in total

Review 1.  Mammary and extramammary Paget's disease.

Authors:  J Lloyd; A M Flanagan
Journal:  J Clin Pathol       Date:  2000-10       Impact factor: 3.411

2.  Management of penoscrotal extramammary Paget disease: case series and review of the literature.

Authors:  P Moretto; V J Nair; S El Hallani; S Malone; E Belanger; C Morash; C M Canil
Journal:  Curr Oncol       Date:  2013-08       Impact factor: 3.677

3.  Invasive apocrine carcinoma of the breast: a long term follow-up study of 34 cases.

Authors:  E S d'Amore; M J Terrier-Lacombe; J P Travagli; S Friedman; G Contesso
Journal:  Breast Cancer Res Treat       Date:  1988-09       Impact factor: 4.872

4.  Study of neu-protein expression in mammary Paget's disease with and without underlying breast carcinoma and in extramammary Paget's disease.

Authors:  K Meissner; A Rivière; G Haupt; T Löning
Journal:  Am J Pathol       Date:  1990-12       Impact factor: 4.307

5.  Primary Alopecia Neoplastica: A Novel Case Report and Literature Review.

Authors:  Kelly E Flanagan; Laura J Burns; James T Pathoulas; Chloe J Walker; Isabel Pupo Wiss; Kristine M Cornejo; Maryanne M Senna
Journal:  Skin Appendage Disord       Date:  2021-06-16

6.  Tumour cells of extramammary Paget's disease do not show either p53 mutation or allelic loss at several selected loci implicated in other cancers.

Authors:  M Takata; N Hatta; K Takehara
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

7.  Distinguishing tumour cells of mammary from extramammary Paget's disease using antibodies to two different glycoproteins from human milk-fat-globule membrane.

Authors:  A Imam; S O Yoshida; C R Taylor
Journal:  Br J Cancer       Date:  1988-09       Impact factor: 7.640

8.  Prognostic impact of presumed breast or ovarian cancer among patients with unfavorable-subset cancer of unknown primary site.

Authors:  Makoto Kodaira; Kan Yonemori; Tatsunori Shimoi; Akihiko Yoshida; Masayuki Yoshida; Atsuko Kitano; Akihiko Shimomura; Mayu Yunokawa; Chikako Shimizu; Yuichi Takiguchi; Yasuhiro Fujiwara; Kenji Tamura
Journal:  BMC Cancer       Date:  2018-02-13       Impact factor: 4.430

Review 9.  Diagnostic Immunohistochemistry in Cutaneous Neoplasia: An Update.

Authors:  Leigh A Compton; George F Murphy; Christine G Lian
Journal:  Dermatopathology (Basel)       Date:  2015-04-08

10.  Anal canal adenocarcinoma with neuroendocrine features accompanying secondary extramammary Paget disease, successfully treated with modified FOLFOX6: a case report.

Authors:  Masamichi Yamaura; Takeshi Yamada; Rei Watanabe; Hitomi Kawai; Suguru Hirose; Hiroki Tajima; Masashi Sato; Yuichi Uchida; Daisuke Suganuma; Yoshiyuki Yamamoto; Toshikazu Moriwaki; Ichinosuke Hyodo
Journal:  BMC Cancer       Date:  2018-11-20       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.